Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery.

MLA

Hamai, Yoichi, et al. “Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery.” World Journal of Surgery, vol. 42, no. 5, May 2018, pp. 1496–505. EBSCOhost, https://doi.org/10.1007/s00268-017-4283-1.

APA

Hamai, Y., Hihara, J., Emi, M., Furukawa, T., Murakami, Y., Nishibuchi, I., Ibuki, Y., Yamakita, I., Kurokawa, T., Nagata, Y., & Okada, M. (2018). Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery. World Journal of Surgery, 42(5), 1496–1505. https://doi.org/10.1007/s00268-017-4283-1

Chicago

Hamai, Yoichi, Jun Hihara, Manabu Emi, Takaoki Furukawa, Yuji Murakami, Ikuno Nishibuchi, Yuta Ibuki, et al. 2018. “Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery.” World Journal of Surgery 42 (5): 1496–1505. doi:10.1007/s00268-017-4283-1.